Subscribe to Biological Therapies in Psychiatry -  Choose your plan >
IN THIS MONTH'S ISSUE:
November 2017

Gabapentinoids: Are They Overprescribed for Pain?
Gabapentinoids are increasingly being prescribed to treat acute, subacute, and chronic noncancer pain, but their safety and efficacy have not been established for these indications.

Too Much Vitamin D
The use of higher than recommended daily doses of supplemental vitamin D has increased in the United States over the past decade across most age groups, races, ethnicities, and both sexes.

Hair Loss with Antidepressants
In a study of hair loss with antidepressants, bupropion (Wellbutrin and others) was associated with the greatest risk; fluoxetine (Prozac and others) and paroxetine (Paxil and others), with the lowest.

Anticholinergics and Mortality in the Elderly
Anticholinergic agents can increase morbidity and mortality in elderly patients.

In Brief
Proton Pump Inhibitors Are Not Associated with an Increased Risk of Alzheimer Disease; Rate of Antidepressant Use in the United States Increases

Risks of Antipsychotics in Patients with Dementia
Antipsychotic drugs are associated with serious morbidity and increased mortality in older people with dementia.

Preventing Suicide in Patients with Bipolar Disorder: Lithium versus Valproate
Suicide-related events in patients with bipolar disorder decreased when the patients took lithium but not when they were treated with valproate (Depakote and others).

Notice to our Subscribers
The December 2017 issue of Biological Therapies in Psychiatry will be our last.

About the BTP Newsletter

Our subscribers say BTP is…

"Very relevant, practical, and thought-provoking."

"About the only thing left without drug ads...objective and balanced."

"Succinct, readable, clear, timely and relevant!"

"Well written and scientifically sound."

Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.

From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.

Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.

We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.